Cardica Receives 510(k) clearance for CABG system

Twitter icon
Facebook icon
LinkedIn icon
e-mail icon
Google icon
The FDA has granted Cardica 510(k) clearance to market its PAS-Port proximal anastomosis system for use in CABG.

The PAS-Port system creates a secure connection, or anastomosis, between a vein graft and the aorta during CABG procedures, according to the Redwood City, Calif.-based company. Currently available in Japan and Europe, where it has been used more than 8,800 times, the PAS-Port system is now commercially available by Cardica in the U.S.

Cardica said that its PAS-Port system allows a surgeon to complete an automated proximal anastomosis without the need to clamp and manipulate the aorta, which could reduce the risk of particle release and ensuing neurocognitive events.